Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2016 Aug;38(6):429–436. doi: 10.1097/MPH.0000000000000555

Table 3.

Logistic regression1 of overweight/obesity among pediatric acute lymphoblastic leukemia survivors at Texas Children's Hospital

Year of Diagnosis ≥1995
Complete Data (n=193 normal weight; 202 overweight/obese) Model 1 (n=153 normal weight; 154 overweight/obese) Model 22 (n=137 normal weight; 139 overweight/obese)
aOR (95% CI) aOR (95% CI) aOR (95% CI)

Age at Diagnosis, year3 1.05 (0.97-1.12) 1.15 (1.04-1.28) 1.14 (1.02-1.29)
Age at Follow up, year 0.98 (0.94-1.02) 0.88 (0.80-0.96) 0.90 (0.81-1.01)
CRT
    None Ref. Ref. Ref.
    Any 3.44 (1.53-7.74) 4.72 (1.32-16.90) 17.45 (1.14-266.26)
Age-by-CRT Interaction 0.84 (0.71-0.98) 0.77 (0.61-0.96) 0.66 (0.45-0.96)
Gender
    Male Ref. Ref. Ref.
    Female 0.74 (0.49-1.13) 0.86 (0.54-1.38) 0.77 (0.45-1.33)
Race/Ethnicity
    Non-Hispanic white Ref. Ref. Ref.
    Hispanic 2.18 (1.40-3.41) 1.89 (1.14-3.13) 2.03 (1.14-3.59)
    Non-Hispanic black 2.33 (0.95-5.69) 2.30 (0.88-5.99) 1.79 (0.56-5.75)
    Other 0.93 (0.38-2.26) 1.08 (0.39-2.96) 1.08 (0.30-3.85)
Diagnosis BMI, z-score NA NA 2.03 (1.57-2.62)

aOR Adjusted Odds Ratio; CI, Confidence Interval; CRT, Cranial Radiation Therapy; BMI, Body Mass Index

1

Adjusted for age at follow up (continuous) and other variables included in table, relative to normal weight, underweight individuals excluded (n=11)

2

Model 2 restricted to patients with height and weight recorded at diagnosis (n=292)

3

Age at diagnosis centered at 7 years